CYTOSORBENTS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9001 USD | +2.28% |
|
+0.01% | -18.91% |
| May. 09 | Earnings Flash (CTSO) CYTOSORBENTS Posts Q1 Revenue $9.8M, vs. Street Est of $9.79M | MT |
| May. 09 | Transcript : Cytosorbents Corporation, Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar Cytosorbents Corporation
f2b59c2abea4f3ca91ee9b1739b5.e1VDqCbnUwCPKcJrDkXjWoRF_8mjBSsHi3uuO6uuxms.OhE00EWSB3Lra50_Rhq3bLEzjo3taX5O3i3Pbd7-nj4_OgLncdE2Wt9q-g~3916b3d893a2d0c045870f1411c6d9e4
Upcoming events on Cytosorbents Corporation
Past events on Cytosorbents Corporation
| 2024-05-09 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-09 04:17 pm | Q1 2024 Earnings Release |
| 2024-05-06 11:30 am | Investor Meeting - Key Opinion Leader |
| 2024-04-28 07:30 am | American Association for Thoracic Surgery Meeting |
| 2024-03-14 04:39 pm | Q4 2023 Earnings Release |
| 2024-03-14 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-06 11:10 am | TD Cowen Health Care Conference |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-09 04:15 pm | Q3 2023 Earnings Release |
| 2023-10-12 02:30 pm | Dawson James Small Cap Growth Conference |
| 2023-10-06 06:15 am | European Association of Cardio Thoracic Surgery Meeting |
| 2023-08-14 | UBS Medtech Tools and Genomics Summit |
| 2023-08-13 | Military Health System Research Symposium |
| 2023-08-01 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-01 04:15 pm | Q2 2023 Earnings Release |
| 2023-06-09 11:30 am | Jefferies Global Healthcare Conference |
| 2023-06-06 10:00 am | Annual General Meeting |
| 2023-05-02 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-02 04:15 pm | Q1 2023 Earnings Release |
| 2023-03-23 07:30 am | ISICEM Congress |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,9 24,9 0.32% | 41,0 39,7 3.21% | 43,2 42,9 0.7% | 34,7 34,1 1.88% | 36,3 37,5 -3.05% | 39,5 |
|
EBITDA Million USD | Released Forecast Spread | -16,7 -15,8 -5.8% | -5,00 -3,17 -57.64% | -15,8 -10,9 -45.11% | -26,8 -27,7 3.05% | -26,0 -22,8 -14.17% | -14,5 |
|
EBIT Million USD | Released Forecast Spread | -19,0 -18,4 -2.94% | -10,4 -9,44 -9.87% | -22,7 -19,3 -17.68% | -31,5 -31,1 -1.51% | -31,2 -27,1 -15.36% | -18,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,4 -20,8 1.92% | -8,96 -8,98 0.21% | -25,3 -22,1 -14.38% | -33,9 -38,7 12.4% | -29,3 -27,9 -5.04% | -20,4 |
|
Net income Million USD | Released Forecast Spread | -19,3 -20,8 7.18% | -7,84 -8,98 12.76% | -24,6 -21,6 -13.66% | -32,8 -38,7 15.22% | -28,5 -27,9 -2.13% | -20,4 |
|
EPS USD | Released Forecast Spread | -0,60 -0,64 6.61% | -0,20 -0,23 11.39% | -0,57 -0,48 -18.26% | -0,75 -0,89 15.25% | -0,64 -0,62 -3.23% | -0,37 |
| Announcement Date | 05/03/20 | 09/03/21 | 08/03/22 | 09/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8,69 9,97 -12.79% | 8,50 9,56 -11.17% | 8,11 8,52 -4.79% | 9,39 8,75 7.32% | 9,45 8,73 8.19% | 9,42 10,2 -7.65% | 8,81 9,32 -5.44% | 8,67 9,84 -11.91% | 9,79 9,78 0.02% | 9,73 | 9,89 | 10,1 | 11,4 | 11,9 |
|
EBITDA Million USD | Released Forecast Spread | -5,04 -5,20 3.14% | -5,48 -4,19 -30.72% | -7,89 -2,94 -168.74% | -3,60 -5,49 34.38% | -3,81 | -3,22 | -3,11 | |||||||
|
EBIT Million USD | Released Forecast Spread | -7,79 -3,55 -119.46% | -8,36 -5,14 -62.66% | -9,02 -6,22 -44.95% | -6,36 -6,07 -4.78% | -7,89 -5,50 -43.49% | -6,56 -6,26 -4.7% | -7,35 -5,67 -29.62% | -9,34 -5,73 -63.02% | -4,93 -7,19 31.49% | -4,88 | -4,59 | -4,42 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,97 -4,15 -116.05% | -10,9 -5,47 -98.85% | -12,2 -7,05 -72.97% | -1,86 -6,73 72.39% | -7,33 -6,10 -20.1% | -6,15 -6,31 2.56% | -9,19 -5,53 -66.31% | -6,65 -5,69 -16.74% | -6,36 -7,12 10.66% | -4,84 | -4,55 | -4,38 | ||
|
Net income Million USD | Released Forecast Spread | -8,97 -4,15 -116.05% | -10,9 -5,47 -98.85% | -12,2 -7,05 -72.97% | -0,77 -6,73 88.61% | -7,33 -6,10 -20.1% | -6,15 -6,31 2.56% | -9,19 -5,53 -66.31% | -5,83 -5,69 -2.45% | -6,36 -7,12 10.66% | -4,84 | -4,55 | -4,38 | ||
|
EPS USD | Released Forecast Spread | -0,21 -0,14 -50% | -0,25 -0,12 -102.71% | -0,28 -0,16 -71.43% | -0,01 -0,15 93.44% | -0,17 -0,13 -34.21% | -0,14 -0,14 -2.44% | -0,21 -0,12 -75% | -0,12 -0,11 -9.09% | -0,12 -0,12 0% | -0,09 | -0,08 | -0,08 | -0,05 | -0,05 |
| Announcement Date | 03/05/22 | 02/08/22 | 03/11/22 | 09/03/23 | 02/05/23 | 01/08/23 | 09/11/23 | 14/03/24 | 09/05/24 | - | - | - | - | - |
More events
Past sector events for Cytosorbents Corporation
| 2024-05-29 04:05 pm | AGILENT TECHNOLOGIES, INC.: Q2 2024 Earnings Release |
| 2024-05-14 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-12 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
| 2024-05-09 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 2024-05-08 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-08 04:05 pm | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:01 pm | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 2024-05-08 01:00 am | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
| 2024-05-07 | CLASSYS INC.: Q1 2024 Earnings Release |
| 2024-05-07 04:00 pm | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTSO Stock
- Calendar Cytosorbents Corporation
